General Medicine; SARS-CoV-2; Artificial Intelligence; CT scan analysis
Résumé :
[en] The pandemic of COVID-19 led to a dramatic situation in hospitals, where staff had to deal with a huge number of patients in respiratory distress. To alleviate the workload of radiologists, we implemented an artificial intelligence (AI) - based analysis named CACOVID-CT, to automatically assess disease severity on chest CT scans obtained from those patients. We retrospectively studied CT scans obtained from 476 patients admitted at the University Hospital of Liege with a COVID-19 disease. We quantified the percentage of COVID-19 affected lung area (% AA) and the CT severity score (total CT-SS). These quantitative measurements were used to investigate the overall prognosis and patient outcome: hospital length of stay (LOS), ICU admission, ICU LOS, mechanical ventilation, and in-hospital death. Both CT-SS and % AA were highly correlated with the hospital LOS, the risk of ICU admission, the risk of mechanical ventilation and the risk of in-hospital death. Thus, CAD4COVID-CT analysis proved to be a useful tool in detecting patients with higher hospitalization severity risk. It will help for management of the patients flow. The software measured the extent of lung damage with great efficiency, thus relieving the workload of radiologists.
H2020 - 101005122 - DRAGON - The RapiD and SecuRe AI enhAnced DiaGnosis, Precision Medicine and Patient EmpOwerment Centered Decision Support System for Coronavirus PaNdemics
Organisme subsidiant :
EU - European Union IMI - Innovative Medicines Initiative
Hope M Raptis CA Shah A Hammer MA Henry TS. A role for CT in COVID-19? What data tell us really so far. Lancet. (2020) 395:1189–90. 10.1016/S0140-6736(20)30728-5 32224299
Covid-Icu Group on behalf of the Reva Network and the Covid-Icu Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: A prospective cohort study. Intensive Care Med. (2021) 47:60–73. 10.1007/s00134-020-06294-x 33211135
Guiot J Vaidyanathan A Deprez L Zerka F Danthine D Frix AN et al. Development and validation of an automated radiomic CT signature for detecting COVID-19. Diagnostics. (2021) 11:41. 10.3390/diagnostics11010041 33396587
Walsh SLF Calandriello L Silva M Sverzellati N. Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: A case-cohort study. Lancet Respir Med. (2018) 6:837–45. 10.1016/S2213-2600(18)30286-8 30232049
Liu X Zhou H Zhou Y Wu X Zhao Y Lu Y et al. Temporal radiographic changes in COVID-19 patients: Relationship to disease severity and viral clearance. Sci Rep. (2020) 10:10263. 10.1038/s41598-020-66895-w 32581324
Salehi S Abedi A Balakrishnan S Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19) imaging reporting and data system (COVID-RADS) and common lexicon: A proposal based on the imaging data of 37 studies. Eur Radiol. (2020) 30:4930–42. 10.1007/s00330-020-06863-0 32346790
de Smet K de Smet D Ryckaert T Laridon E Heremans B Vandenbulcke R et al. Diagnostic performance of chest CT for SARS-CoV-2 infection in individuals with or without COVID-19 symptoms. Radiology. (2020) 298:E30–7.
Kardos AS Simon J Nardocci C Szabó IV Nagy N Abdelrahman RH et al. The diagnostic performance of deep-learning-based CT severity score to identify COVID-19 pneumonia. Br J Radiol. (2022) 95:20210759.
Bai HX Hsieh B Xiong Z Halsey K Choi JW Tran TML et al. Performance of radiologists in differentiating COVID-19 from Non-COVID-19 viral pneumonia at chest CT. Radiology. (2020) 296:E46–54.
Lessmann N Sánchez CI Beenen L Boulogne LH Brink M Calli E et al. Automated assessment of CO-RADS and chest CT severity scores in patients with suspected COVID-19 using artificial intelligence. Radiology. (2021) 298:E18–28. 10.1148/radiol.2020202439 32729810
Lambin P Rios-Velazquez E Leijenaar R Carvalho S van Stiphout RGPM Granton P et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer. (2012) 48:441–6.
Kanne JP Bai H Bernheim A Chung M Haramati LB Kallmes DF et al. COVID-19 Imaging: What we know now and what remains unknown. Radiology. (2021) 299:E262–79. 10.1148/radiol.2021204522 33560192
Xiong Z Wang R Bai HX Halsey K Mei J Li YH et al. Artificial intelligence augmentation of radiologist performance in distinguishing COVID-19 from pneumonia of other origin at chest CT. Radiology. (2020) 296:E156–65.
Prokop M van Everdingen W van Rees Vellinga T van Ufford HQ Stöger L Beenen L et al. CO-RADS: A categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation. Radiology. (2020) 296:E97–104. 10.1148/radiol.2020201473 32339082
Frix AN Cousin F Refaee T Bottari F Vaidyanathan A Desir C et al. Radiomics in lung diseases imaging: State-of-the-art for clinicians. J Pers Med. (2021) 11:602.
Francone M Iafrate F Masci GM Coco S Cilia F Manganaro L et al. Chest CT score in COVID-19 patients: Correlation with disease severity and short-term prognosis. Eur Radiol. (2020) 30:6808.
Sharifpour A Safanavaei S Tabaripour R Taghizadeh F Nakhaei M Abadi A et al. Alkaline phosphatase and score of HRCT as indicators for predicting the severity of COVID-19. Ann Med Surg. (2021) 67:102519. 10.1016/j.amsu.2021.102519 34191992
Huespe I Carboni Bisso I di Stefano S Terrasa S Gemelli NA las Heras M. COVID-19 severity index: A predictive score for hospitalized patients. Med Intensiva. (2022) 46:98–101.
Bennouar S Bachir Cherif A Kessira A Bennouar DE Abdi S. Development and validation of a laboratory risk score for the early prediction of COVID-19 severity and in-hospital mortality. Intensive Crit Care Nurs. (2021) 64:103012.
sciensano.be. Overweight and obesity in Belgium – Numbers. (2022). Available online at: https://www.sciensano.be/en/health-topics/obesity/numbers#overweight-and-obesity-in-belgium (accessed March 31, 2022)
Smati S Tramunt B Wargny M Seret-Bégué D Winiszewski P Matthieu P et al. Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study. Diabetes Obes Metab. (2020) 23:391–403. 10.1111/dom.14228 33051976
Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: The end of the beginning. Cell Metab. (2021) 33:479. 10.1016/j.cmet.2021.01.016 33529600
Zhou F Yu T Du R Fan G Liu Y Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. (2020) 395:1054–62. 10.1016/S0140-6736(20)30566-3 32171076
Gao M Piernas C Astbury NM Hippisley-Cox J O’Rahilly S Aveyard P et al. Associations between body-mass index and COVID-19 severity in 6⋅9 million people in England: A prospective, community-based, cohort study. Lancet Diabetes Endocrinol. (2021) 9:350–9. 10.1016/S2213-8587(21)00089-9 33932335
Lambermont B Rousseau AF Seidel L Thys M Cavalleri J Delanaye P et al. outcome improvement between the first two Waves of the coronavirus disease 2019 pandemic in a single tertiary-care hospital in Belgium. Crit Care Explor. (2021) 3:e0438. 10.1097/CCE.0000000000000438 34079951
Darcis G Bouquegneau A Maes N Thys M Henket M Labye F et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: A monocentric prospective observational cohort study. Int J Infect Dis. (2021) 109:209–16. 10.1016/j.ijid.2021.07.016 34273510
Ojha V Mani A Pandey NN Sharma S Kumar S. CT in coronavirus disease 2019 (COVID-19): A systematic review of chest CT findings in 4410 adult patients. Eur Radiol. (2020) 30:6129–38. 10.1007/s00330-020-06975-7 32474632
